Pneumonia severity index: Difference between revisions
Jump to navigation
Jump to search
imported>Chris Day |
imported>Robert Badgett No edit summary |
||
| Line 7: | Line 7: | ||
A [[randomized controlled trial]] found that use of the PSI to guide management of [[community acquired pneumonia]] improved medical care by reducing resource consumption without reducing quality of care.<ref name="pmid10683053">{{cite journal |author=Marrie TJ, Lau CY, Wheeler SL, Wong CJ, Vandervoort MK, Feagan BG |title=A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin |journal=JAMA |volume=283 |issue=6 |pages=749-55 |year=2000 |pmid=10683053 |doi=}}</ref> | A [[randomized controlled trial]] found that use of the PSI to guide management of [[community acquired pneumonia]] improved medical care by reducing resource consumption without reducing quality of care.<ref name="pmid10683053">{{cite journal |author=Marrie TJ, Lau CY, Wheeler SL, Wong CJ, Vandervoort MK, Feagan BG |title=A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin |journal=JAMA |volume=283 |issue=6 |pages=749-55 |year=2000 |pmid=10683053 |doi=}}</ref> | ||
Removing the effect of age may improve accuracy.<ref name="pmid20965934">{{cite journal| author=Chen JH, Chang SS, Liu JJ, Chan RC, Wu JY, Wang WC et al.| title=Comparison of clinical characteristics and performance of pneumonia severity score and CURB-65 among younger adults, elderly and very old subjects. | journal=Thorax | year= 2010 | volume= 65 | issue= 11 | pages= 971-7 | pmid=20965934 | doi=10.1136/thx.2009.129627 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20965934 }} </ref> | |||
The pneumonia severity index has been compared to the [[CURB-65]] in predicting mortality.<ref name="pmid15808136">{{cite journal |author=Aujesky D, Auble TE, Yealy DM, ''et al'' |title=Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia |journal=Am. J. Med. |volume=118 |issue=4 |pages=384-92 |year=2005 |pmid=15808136 |doi=10.1016/j.amjmed.2005.01.006}}</ref> | The pneumonia severity index has been compared to the [[CURB-65]] in predicting mortality.<ref name="pmid15808136">{{cite journal |author=Aujesky D, Auble TE, Yealy DM, ''et al'' |title=Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia |journal=Am. J. Med. |volume=118 |issue=4 |pages=384-92 |year=2005 |pmid=15808136 |doi=10.1016/j.amjmed.2005.01.006}}</ref> | ||
Revision as of 09:58, 27 December 2010
The pneumonia severity index (PSI) is a clinical prediction rule to estimate the probability of complications among patients with community acquired pneumonia.[1]
The accuracy of the PSI has been independently validated by other researchers.[2]
Patients with PSI Risk groups I-III can usually be treated as an outpatient.[3]
A randomized controlled trial found that use of the PSI to guide management of community acquired pneumonia improved medical care by reducing resource consumption without reducing quality of care.[4]
Removing the effect of age may improve accuracy.[5]
The pneumonia severity index has been compared to the CURB-65 in predicting mortality.[2]
References
- ↑ Fine MJ, Auble TE, Yealy DM, et al (1997). "A prediction rule to identify low-risk patients with community-acquired pneumonia". N. Engl. J. Med. 336 (4): 243–50. PMID 8995086. [e]
- ↑ 2.0 2.1 Aujesky D, Auble TE, Yealy DM, et al (2005). "Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia". Am. J. Med. 118 (4): 384-92. DOI:10.1016/j.amjmed.2005.01.006. PMID 15808136. Research Blogging.
- ↑ Carratalà J, Fernández-Sabé N, Ortega L, et al (February 2005). "Outpatient care compared with hospitalization for community-acquired pneumonia: a randomized trial in low-risk patients". Ann. Intern. Med. 142 (3): 165–72. PMID 15684204. [e]
- ↑ Marrie TJ, Lau CY, Wheeler SL, Wong CJ, Vandervoort MK, Feagan BG (2000). "A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin". JAMA 283 (6): 749-55. PMID 10683053. [e]
- ↑ Chen JH, Chang SS, Liu JJ, Chan RC, Wu JY, Wang WC et al. (2010). "Comparison of clinical characteristics and performance of pneumonia severity score and CURB-65 among younger adults, elderly and very old subjects.". Thorax 65 (11): 971-7. DOI:10.1136/thx.2009.129627. PMID 20965934. Research Blogging.